Literature DB >> 16488380

Status epilepticus: pathophysiology and management in adults.

James W Y Chen1, Claude G Wasterlain.   

Abstract

As in Clark and Prout's classic work, we identify three phases of generalised convulsive status epilepticus, which we call impending, established, and subtle. We review physiological and subcellular changes that might play a part in the transition from single seizures to status epilepticus and in the development of time-dependent pharmacoresistance. We review the principles underlying the treatment of status epilepticus and suggest that prehospital treatment is beneficial, that therapeutic drugs should be used in rapid sequence according to a defined protocol, and that refractory status epilepticus should be treated with general anaesthesia. We comment on our preference for drugs with a short elimination half-life and discuss some therapeutic choices.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16488380     DOI: 10.1016/S1474-4422(06)70374-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  88 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

2.  Treatment of refractory status epilepticus in childhood.

Authors:  John M Schreiber; William D Gaillard
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

3.  Treatment of pediatric status epilepticus.

Authors:  Tobias Loddenkemper; Howard P Goodkin
Journal:  Curr Treat Options Neurol       Date:  2011-12       Impact factor: 3.598

4.  Refractory status epilepticus: is EEG burst suppression an appropriate treatment target during drug-induced coma? What is the Holy Grail?

Authors:  Gregory K Bergey
Journal:  Epilepsy Curr       Date:  2006 Jul-Aug       Impact factor: 7.500

5.  New data suggest that discontinuation of status epilepticus is not necessary for antiepileptogenic effect in immature brain.

Authors:  Asla Pitkänen
Journal:  Epilepsy Curr       Date:  2006 Sep-Oct       Impact factor: 7.500

6.  New developments in antiepileptic drug resistance: an integrative view.

Authors:  Dieter Schmidt; Wolfgang Löscher
Journal:  Epilepsy Curr       Date:  2009 Mar-Apr       Impact factor: 7.500

Review 7.  Treatment of Generalized Convulsive Status Epilepticus in Pediatric Patients.

Authors:  Elizabeth L Alford; James W Wheless; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug

8.  Central neurological complications in critically ill patients with malignancies.

Authors:  Stéphane Legriel; Hélène Marijon; Michael Darmon; Virginie Lemiale; Jean-Pierre Bedos; Benoît Schlemmer; Elie Azoulay
Journal:  Intensive Care Med       Date:  2009-11-12       Impact factor: 17.440

9.  Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts.

Authors:  Luca Vignatelli; Rita Rinaldi; Elisa Baldin; Paolo Tinuper; Roberto Michelucci; Massimo Galeotti; Piero de Carolis; Roberto D'Alessandro
Journal:  J Neurol       Date:  2008-01-23       Impact factor: 4.849

10.  Genetic variability in glutamic acid decarboxylase genes: associations with post-traumatic seizures after severe TBI.

Authors:  Shaun D Darrah; Megan A Miller; Dianxu Ren; Nichole Z Hoh; Joelle M Scanlon; Yvette P Conley; Amy K Wagner
Journal:  Epilepsy Res       Date:  2012-07-26       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.